Regulators agree on Covid-19 vaccination adaptation plan

On June 30, representatives of regulatory authorities from around the world met to discuss the adaptation of the existing Covid-19 vaccines in response to new Omicron variants of concern.

Photo: Finn Frandsen

Despite the fact that evidence examined by regulatory authorities around the world and the World Health Organization (WHO) suggests that the first generation of Covid-19 vaccines still protects against serious illness, hospitalization and death, the organizations are keeping a close eye on new variants.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs